We recently spoke to Richard Ashcroft, Professor of Bioethics and Head Deputy of the Department of Law at Queen Mary University to learn more about the importance of addressing ethical questions in the emerging field of genetic engineering. Read on for more.
Fixing genes, introducing them to a patient and making the patient's body accept the newly introduced genes are challenges we were not able to overcome until recently. Now, with the advance of genome editing techniques and the use of stem cells, we are closer than ever. Here we bring you the insight on how it would work to combine these two biological tools to fight disease.
The advent of CRISPR has meant that gene editing in humans is becoming a reality. But what are the realistic medical outcomes and potential hiccups of this new technology?
The first SIUFocus event took place in London on April 27th. Our 3 speakers remarked on the power of big data and shed light on how they use artificial intelligence and data science techniques to efficiently use it in healthcare and life sciences research. Here is the summary of what we learned from them during the inspirational event that evening.
When I tell friends that I did research on something called CRISPR, the first response is often a raised eyebrow and a belief that I’m making some terrible potato-related joke.
James explores the origins, development, scientific background and subsequent business activities surrounding the emergence of this tremendously powerful gene editing technique.
In a controversial paper published in the journal Protein & Cell earlier this year, Chinese scientists at Sun Yat-sen University reported the world’s first genomic editing of human embryos
The technology known as CRISPR/Cas9 has been described as the 'holy grail' of genetic engineering, and has become the hottest research area because of its potential to cure many diseases by 'editing' DNA.